Aug. 10, 2011 -- Two of three patients dying of chronic lymphocytic leukemia (CLL) appear cured and a third is in partial remission after infusions of genetically engineered T cells...."Our results were absolutely dramatic. It is tremendously exciting," Porter tells WebMD.